Xona Microfluidics, Inc.
NC Doing business as Xona Microfluids LLC
- UEI
- WKANFDSH6263
- CAGE
- 6E3X2
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 76 TW Alexander Dr, Research Triangle, NC 27709, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $36,675 |
Contract awards
Grant awards
Similar vendors
About the company
Xona Microfluidics, Inc. is a for-profit manufacturer that provides microfluidic goods and services to federal agencies. Through prime federal contract awards, Xona Microfluidics has provided microfluidic chambers and microgroove barriers to the Department of Veterans Affairs. Through a prime federal grant from the National Institute on Aging, Xona Microfluidics is developing an assay to screen therapeutics that prevent tau protein mislocalization in Alzheimer's disease. Through another prime federal grant from the National Institute of Neurological Disorders and Stroke, Xona Microfluidics is studying the influence of axonal endoplasmic reticulum on synapse loss after axon damage.
Xona Microfluidics has received three prime federal contract awards from the Department of Veterans Affairs to provide microfluidic goods. These include purchase orders for Xona double open microfluidic devices, laboratory microfluidic chambers, and RD Series microgroove barriers. The contract awards ranged from $31,610 to $36,675 in potential value.
Through a $1.6 million prime federal grant from the National Institute on Aging, Xona Microfluidics is developing a tau mislocalization assay to screen Alzheimer's disease therapeutics using compartmentalized microfluidic chips and human induced pluripotent stem cell derived neurons. Through a $666,313 prime federal grant from the National Institute of Neurological Disorders and Stroke, Xona Microfluidics is studying the influence of axonal endoplasmic reticulum on synapse loss after axon damage.
Quick answers
Is Xona Microfluidics, Inc. registered in SAM.gov?
Yes. Xona Microfluidics, Inc.'s SAM.gov registration is active through July 11, 2027.
How much has Xona Microfluidics, Inc. received in federal contracts?
Federal contracts obligated $36,675 to Xona Microfluidics, Inc. in fiscal years 2023 through 2027.
What is Xona Microfluidics, Inc.'s most recent federal award?
Xona Microfluidics, Inc.'s most recent federal contract award is Xona double open (36C24123P0464), from Veterans Integrated Service Network 1 (VHA), on May 25, 2023.
On GovTribe
See Xona Microfluidics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors